Alpha Cognition (ACOG) Treasury Shares (2024 - 2025)

Alpha Cognition's (ACOG) quarterly Treasury Shares came in at $3.5 million in Q3 2025, down 3.79% quarter-over-quarter from $3.6 million in Q2 2025.

Alpha Cognition (ACOG) Treasury Shares (2024 - 2025) Analysis & Trends

Alpha Cognition's Treasury Shares history runs 2 years deep, the most recent figure standing at $3.5 million for Q3 2025.

On a quarterly basis, Treasury Shares changed N/A year-over-year to $3.5 million in Q3 2025; TTM through Sep 2025 was $3.5 million, a N/A change from a year earlier, with the FY2024 full-year figure at $3.6 million, changed N/A from the prior year.
Treasury Shares retreated to $3.5 million in Q3 2025 per ACOG's latest filing, from $3.6 million in the prior quarter.
Across five years, Treasury Shares topped out at $3.6 million in Q4 2024 and bottomed at $3.5 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-21,709.08
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	265,401.92
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	19.41 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	5.14 Mn
10	Alpha Cognition	145.51 Mn	79.41 Mn	2.61 Mn	-

Download Data